Please join us for an Open Scientific Discussion (OSD) hosted by the Biomarkers and Precision Medicine (BPM) Community on July 9, from 1-2 PM ET on the following topic:
Multi-Parametric Biomarker Signatures
· How do we go from identifying a potential biomarker with omics tools to an assay that is used in clinical trials?
· Examples of biomarker panel assay use: Renal safety biomarkers, Alzheimer’s disease, pharmacodynamic signatures
· Challenges in establishing and translating multi-parameter biomarker assays to the clinic
Discussion Leaders:
Tom Lanz (Pfizer)
Tim West (C2N Diagnostics)
Chris Whelan (formerly Johnson & Johnson)
Organized by:
Joel Matthews (Ionis Pharmaceuticals)
Jurre Kamphorst (AstraZeneca)
Carmen Fernández-Metzler (PharmaCadence Analytical Services)
Karen Quadrini (Prothena Biosciences)
We start at 1:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.
(Please remain on mute unless asking questions)
When: Wednesday July 9, 2025, 1 pm – 2 pm ET
Where: Please join from your computer, tablet or smartphone.
Microsoft Teams Need help?
Join the meeting now
Meeting ID: 279 600 469 385 3
Passcode: jg3oC6Uj
Please feel free to share with colleagues who may be interested in this topic. Thank you!
The AAPS BPM Community Leadership Team